A phase IIb clinical study to evaluate SB010 in patients with uncontrolled, moderate to severe asthma

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 11 Jan 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Jan 2021 According to a sterna biologicals media release, the company is planning to start phase IIb development of SB010 in 2023.
12 Mar 2019 According to a sterna biologicals media release, company held two Scientific Advisory Board (SAB) meetings, of which first took place on February 23, 2019, during the 2019 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting and second in Frankfurt/Main, Germany on March 4, 2019. In this meeting design of this trial was discussed and further solidified.
22 Jan 2019 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com